These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 22442145)

  • 1. Advanced bone formation in mice with a dominant-negative mutation in the thyroid hormone receptor β gene due to activation of Wnt/β-catenin protein signaling.
    O'Shea PJ; Kim DW; Logan JG; Davis S; Walker RL; Meltzer PS; Cheng SY; Williams GR
    J Biol Chem; 2012 May; 287(21):17812-17822. PubMed ID: 22442145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrasting skeletal phenotypes in mice with an identical mutation targeted to thyroid hormone receptor alpha1 or beta.
    O'Shea PJ; Bassett JH; Sriskantharajah S; Ying H; Cheng SY; Williams GR
    Mol Endocrinol; 2005 Dec; 19(12):3045-59. PubMed ID: 16051666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Canonical Thyroid Hormone Receptor β Action Stimulates Hepatocyte Proliferation in Male Mice.
    Hönes GS; Kerp H; Hoppe C; Kowalczyk M; Zwanziger D; Baba HA; Führer D; Moeller LC
    Endocrinology; 2022 Mar; 163(3):. PubMed ID: 35038735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of fibroblast growth factor receptor-1 (FGFR1) by thyroid hormone: identification of a thyroid hormone response element in the murine Fgfr1 promoter.
    O'Shea PJ; Guigon CJ; Williams GR; Cheng SY
    Endocrinology; 2007 Dec; 148(12):5966-76. PubMed ID: 17761769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Marked potentiation of the dominant negative action of a mutant thyroid hormone receptor beta in mice by the ablation of one wild-type beta allele.
    Suzuki H; Zhang XY; Forrest D; Willingham MC; Cheng SY
    Mol Endocrinol; 2003 May; 17(5):895-907. PubMed ID: 12576488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of beta-catenin by a novel nongenomic action of thyroid hormone beta receptor.
    Guigon CJ; Zhao L; Lu C; Willingham MC; Cheng SY
    Mol Cell Biol; 2008 Jul; 28(14):4598-608. PubMed ID: 18474620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the canonical Wnt pathway by high glucose can be reversed by parathyroid hormone-related protein in osteoblastic cells.
    López-Herradón A; Portal-Núñez S; García-Martín A; Lozano D; Pérez-Martínez FC; Ceña V; Esbrit P
    J Cell Biochem; 2013 Aug; 114(8):1908-16. PubMed ID: 23494914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of thyroid hormone receptor isoforms dictates the dominant negative activity of mutant Beta receptor.
    Zhang XY; Kaneshige M; Kamiya Y; Kaneshige K; McPhie P; Cheng SY
    Mol Endocrinol; 2002 Sep; 16(9):2077-92. PubMed ID: 12198244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid Hormone Receptor α Plays an Essential Role in Male Skeletal Muscle Myoblast Proliferation, Differentiation, and Response to Injury.
    Milanesi A; Lee JW; Kim NH; Liu YY; Yang A; Sedrakyan S; Kahng A; Cervantes V; Tripuraneni N; Cheng SY; Perin L; Brent GA
    Endocrinology; 2016 Jan; 157(1):4-15. PubMed ID: 26451739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An unliganded thyroid hormone beta receptor activates the cyclin D1/cyclin-dependent kinase/retinoblastoma/E2F pathway and induces pituitary tumorigenesis.
    Furumoto H; Ying H; Chandramouli GV; Zhao L; Walker RL; Meltzer PS; Willingham MC; Cheng SY
    Mol Cell Biol; 2005 Jan; 25(1):124-35. PubMed ID: 15601836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor suppressor action of liganded thyroid hormone receptor beta by direct repression of beta-catenin gene expression.
    Guigon CJ; Kim DW; Zhu X; Zhao L; Cheng SY
    Endocrinology; 2010 Nov; 151(11):5528-36. PubMed ID: 20844001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skeletal effects of nongenomic thyroid hormone receptor beta signaling.
    Lindsey RC; Godwin C; Mohan S
    J Endocrinol; 2019 Sep; 242(3):173-183. PubMed ID: 31252404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of TSH in the spontaneous development of asymmetrical thyroid carcinoma in mice with a targeted mutation in a single allele of the thyroid hormone-β receptor.
    Zhao L; Zhu X; Won Park J; Fozzatti L; Willingham M; Cheng SY
    Endocrinology; 2012 Oct; 153(10):5090-100. PubMed ID: 22919057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of tumor cell proliferation by thyroid hormone in a mouse model of follicular thyroid carcinoma.
    Lu C; Zhu X; Willingham MC; Cheng SY
    Oncogene; 2012 Apr; 31(16):2007-16. PubMed ID: 21909131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid hormone interacts with the Wnt/beta-catenin signaling pathway in the terminal differentiation of growth plate chondrocytes.
    Wang L; Shao YY; Ballock RT
    J Bone Miner Res; 2007 Dec; 22(12):1988-95. PubMed ID: 17708712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic signaling of KRAS and thyroid hormone receptor β mutants promotes undifferentiated thyroid cancer through MYC up-regulation.
    Zhu X; Zhao L; Park JW; Willingham MC; Cheng SY
    Neoplasia; 2014 Sep; 16(9):757-69. PubMed ID: 25246276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation of thyroid hormone receptor-β in mice predisposes to the development of mammary tumors.
    Guigon CJ; Kim DW; Willingham MC; Cheng SY
    Oncogene; 2011 Jul; 30(30):3381-90. PubMed ID: 21399657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-Catenin Directs Long-Chain Fatty Acid Catabolism in the Osteoblasts of Male Mice.
    Frey JL; Kim SP; Li Z; Wolfgang MJ; Riddle RC
    Endocrinology; 2018 Jan; 159(1):272-284. PubMed ID: 29077850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid hormone receptor β sumoylation is required for thyrotropin regulation and thyroid hormone production.
    Ke S; Liu YY; Karthikraj R; Kannan K; Jiang J; Abe K; Milanesi A; Brent GA
    JCI Insight; 2021 Aug; 6(16):. PubMed ID: 34237030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation by steroid receptor coactivator-1 of target-tissue responsiveness in resistance to thyroid hormone.
    Kamiya Y; Zhang XY; Ying H; Kato Y; Willingham MC; Xu J; O'Malley BW; Cheng SY
    Endocrinology; 2003 Sep; 144(9):4144-53. PubMed ID: 12933689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.